Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey

Robert Udelsman, William T. Gallucci, John Bacher, Donald (Lynn) Loriaux, George P. Chrousos

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Right atrial bolus administration of rat/human corticotropin releasing hormone (r/hCRH) at a dose of 90 μg/kg to anesthetized cynomolgus monkeys caused a dramatic and prolonged fall in both the peripheral vascular resistance (48% reduction) and mean systemic blood pressure (36% reduction). An associated tachycardia could be blocked with prior propranolol administration and thus was probably reflexic. A mean 43 and 37% increase in the flow of the superior mesenteric and common iliac arteries, respectively, was demonstrated with electromagnetic flow probes. These changes were associated with a concomitant 38 and 40% dimunution in the respective vascular resistance. Similar blood flow changes were noted in the carotid artery, however, these were of a much shorter duration. None of these changes occurred in placebo-treated animals. Plasma adrenocorticotropic hormone and cortisol concentrations were elevated basally and throughout the procedure and were similar in the experimental and control groups, suggesting maximal activity of the hypothalamic-pituitary-adrenal axis. Plasma renin activity, however, gradually increased in the r/hCRH-treated animals, probably as a result of the systemic hypotension. We speculate that CRH or a CRH-like substance may function as a paracrine hormone modulating local blood vessel tone and may be important in directing blood flow during stress and injury. The vasoactive properties of exogenous r/hCRH may be of clinical use in man.

Original languageEnglish (US)
Pages (from-to)465-471
Number of pages7
JournalPeptides
Volume7
Issue number3
DOIs
StatePublished - 1986
Externally publishedYes

Fingerprint

Macaca fascicularis
Corticotropin-Releasing Hormone
Hemodynamics
Vascular Resistance
Rats
Animals
Blood
Plasmas
Iliac Artery
Electromagnetic Phenomena
Blood pressure
Blood vessels
Plastic flow
Carotid Arteries
Renin
Tachycardia
Propranolol
Hypotension
Adrenocorticotropic Hormone
Blood Vessels

Keywords

  • Corticotropin releasing hormone
  • Cynomolgus monkey
  • Vasodilator

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey. / Udelsman, Robert; Gallucci, William T.; Bacher, John; Loriaux, Donald (Lynn); Chrousos, George P.

In: Peptides, Vol. 7, No. 3, 1986, p. 465-471.

Research output: Contribution to journalArticle

Udelsman, Robert ; Gallucci, William T. ; Bacher, John ; Loriaux, Donald (Lynn) ; Chrousos, George P. / Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey. In: Peptides. 1986 ; Vol. 7, No. 3. pp. 465-471.
@article{db029c3d91c5432298440f9cf45d28d7,
title = "Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey",
abstract = "Right atrial bolus administration of rat/human corticotropin releasing hormone (r/hCRH) at a dose of 90 μg/kg to anesthetized cynomolgus monkeys caused a dramatic and prolonged fall in both the peripheral vascular resistance (48{\%} reduction) and mean systemic blood pressure (36{\%} reduction). An associated tachycardia could be blocked with prior propranolol administration and thus was probably reflexic. A mean 43 and 37{\%} increase in the flow of the superior mesenteric and common iliac arteries, respectively, was demonstrated with electromagnetic flow probes. These changes were associated with a concomitant 38 and 40{\%} dimunution in the respective vascular resistance. Similar blood flow changes were noted in the carotid artery, however, these were of a much shorter duration. None of these changes occurred in placebo-treated animals. Plasma adrenocorticotropic hormone and cortisol concentrations were elevated basally and throughout the procedure and were similar in the experimental and control groups, suggesting maximal activity of the hypothalamic-pituitary-adrenal axis. Plasma renin activity, however, gradually increased in the r/hCRH-treated animals, probably as a result of the systemic hypotension. We speculate that CRH or a CRH-like substance may function as a paracrine hormone modulating local blood vessel tone and may be important in directing blood flow during stress and injury. The vasoactive properties of exogenous r/hCRH may be of clinical use in man.",
keywords = "Corticotropin releasing hormone, Cynomolgus monkey, Vasodilator",
author = "Robert Udelsman and Gallucci, {William T.} and John Bacher and Loriaux, {Donald (Lynn)} and Chrousos, {George P.}",
year = "1986",
doi = "10.1016/0196-9781(86)90016-1",
language = "English (US)",
volume = "7",
pages = "465--471",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey

AU - Udelsman, Robert

AU - Gallucci, William T.

AU - Bacher, John

AU - Loriaux, Donald (Lynn)

AU - Chrousos, George P.

PY - 1986

Y1 - 1986

N2 - Right atrial bolus administration of rat/human corticotropin releasing hormone (r/hCRH) at a dose of 90 μg/kg to anesthetized cynomolgus monkeys caused a dramatic and prolonged fall in both the peripheral vascular resistance (48% reduction) and mean systemic blood pressure (36% reduction). An associated tachycardia could be blocked with prior propranolol administration and thus was probably reflexic. A mean 43 and 37% increase in the flow of the superior mesenteric and common iliac arteries, respectively, was demonstrated with electromagnetic flow probes. These changes were associated with a concomitant 38 and 40% dimunution in the respective vascular resistance. Similar blood flow changes were noted in the carotid artery, however, these were of a much shorter duration. None of these changes occurred in placebo-treated animals. Plasma adrenocorticotropic hormone and cortisol concentrations were elevated basally and throughout the procedure and were similar in the experimental and control groups, suggesting maximal activity of the hypothalamic-pituitary-adrenal axis. Plasma renin activity, however, gradually increased in the r/hCRH-treated animals, probably as a result of the systemic hypotension. We speculate that CRH or a CRH-like substance may function as a paracrine hormone modulating local blood vessel tone and may be important in directing blood flow during stress and injury. The vasoactive properties of exogenous r/hCRH may be of clinical use in man.

AB - Right atrial bolus administration of rat/human corticotropin releasing hormone (r/hCRH) at a dose of 90 μg/kg to anesthetized cynomolgus monkeys caused a dramatic and prolonged fall in both the peripheral vascular resistance (48% reduction) and mean systemic blood pressure (36% reduction). An associated tachycardia could be blocked with prior propranolol administration and thus was probably reflexic. A mean 43 and 37% increase in the flow of the superior mesenteric and common iliac arteries, respectively, was demonstrated with electromagnetic flow probes. These changes were associated with a concomitant 38 and 40% dimunution in the respective vascular resistance. Similar blood flow changes were noted in the carotid artery, however, these were of a much shorter duration. None of these changes occurred in placebo-treated animals. Plasma adrenocorticotropic hormone and cortisol concentrations were elevated basally and throughout the procedure and were similar in the experimental and control groups, suggesting maximal activity of the hypothalamic-pituitary-adrenal axis. Plasma renin activity, however, gradually increased in the r/hCRH-treated animals, probably as a result of the systemic hypotension. We speculate that CRH or a CRH-like substance may function as a paracrine hormone modulating local blood vessel tone and may be important in directing blood flow during stress and injury. The vasoactive properties of exogenous r/hCRH may be of clinical use in man.

KW - Corticotropin releasing hormone

KW - Cynomolgus monkey

KW - Vasodilator

UR - http://www.scopus.com/inward/record.url?scp=0022885859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022885859&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(86)90016-1

DO - 10.1016/0196-9781(86)90016-1

M3 - Article

C2 - 3490657

AN - SCOPUS:0022885859

VL - 7

SP - 465

EP - 471

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 3

ER -